ZNF404: A Potential Drug Target and Biomarker for Zinc Finger Protein-Containing Diseases
ZNF404: A Potential Drug Target and Biomarker for Zinc Finger Protein-Containing Diseases
Introduction
Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF404, a member of the ZNF gene family, has been identified as a potential drug target and biomarker for a variety of Zinc Finger Protein- containing diseases, including neurodegenerative disorders, diabetes, and cancer.
The ZNF gene family is characterized by the presence of a conserved zinc finger motif, which consists of a nucleotide-binding oligomerization domain (NBD), a zinc finger domain, and a C-terminal TAD (transcription factor binding domain). ZNF404, like other ZNF proteins, is involved in the regulation of gene expression and cell signaling pathways.
Expression and Localization of ZNF404
ZNF404 is a 21-kDa protein that is predominantly expressed in the brain and spinal cord tissues (1,2). It is also expressed in other tissues, including liver, muscle, and placenta. ZNF404 is predominantly localized to the endoplasmic reticulum (ER ) and has been shown to be internalized in the endoplasmic reticulum via a process similar to that of other ZNF proteins, such as ZNF21 and ZNF23 (3,4).
Function of ZNF404
ZNF404 is involved in the regulation of various cellular processes, including cell signaling pathways, cell adhesion, and neurodegenerative disorders.
1. Cell signaling pathways: ZNF404 is involved in the regulation of TGF-β signaling pathway, which is a well-known regulator of cell signaling pathways that plays a crucial role in the development and maintenance of tissues and organs, including the brain and spinal cord. cord (5,6). The TGF-β signaling pathway is involved in the regulation of cell proliferation, differentiation, and survival, and is a potential target for the development of neurodegenerative disorders.
2. Cell adhesion: ZNF404 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. This process is critical for the development and maintenance of tissues and organs, including the brain and spinal cord.
3. Neurodegenerative disorders: ZNF404 is involved in the regulation of the development and progression of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These disorders are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroglial cells.
4. Diabetes: ZNF404 is also involved in the regulation of diabetes, a metabolic disorder that is characterized by the failure of the body to produce or use insulin. ZNF404 has been shown to be involved in the regulation of insulin sensitivity and glucose metabolism, which are critical for the development and progression of diabetes.
5. Cancer: ZNF404 is also involved in the regulation of cancer development and progression. It has been shown to be involved in the regulation of the G1/S transition, which is a critical step in the cell cycle that is associated with the development of cancer.
Potential Therapeutic Applications
The therapeutic potential applications for ZNF404 are vast, as it is involved in the regulation of various cellular processes that are critical for the development and maintenance of tissues and organs.
1. Neurodegenerative disorders: ZNF404 is involved in the regulation of the development and progression of neurodegenerative disorders, making it a potential target
Protein Name: Zinc Finger Protein 404
Functions: May be involved in transcriptional regulation
The "ZNF404 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF404 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540
